QuidelOrtho Corporation

NASDAQ (USD): QuidelOrtho Corporation (QDEL)

Last Price

40.82

Today's Change

+0.42 (1.03%)

Day's Change

39.18 - 40.84

Trading Volume

941,472

Overview

Market Cap

2 Billion

Shares Outstanding

66 Million

Avg Volume

1,139,848

Avg Price (50 Days)

45.69

Avg Price (200 Days)

66.13

PE Ratio

-272.13

EPS

-0.15

Earnings Announcement

08-May-2024

Previous Close

40.40

Open

39.73

Day's Range

39.18 - 40.84

Year Range

37.78 - 95.02

Trading Volume

941,472

Price Change Highlight

1 Day Change

1.04%

5 Day Change

6.89%

1 Month Change

-12.78%

3 Month Change

-41.68%

6 Month Change

-38.38%

Ytd Change

-45.38%

1 Year Change

-55.92%

3 Year Change

-66.08%

5 Year Change

-34.46%

10 Year Change

89.42%

Max Change

696.49%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Medical Instruments & Supplies

Description:

QuidelOrtho Corporation focuses on the development and manufacture of diagnostic testing technologies across the continuum of healthcare testing needs. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; and analyzers and amplification systems. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was founded in 1979 and is headquartered in San Diego, California.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment